aiqbench analysis
MechAInistic leverages a multi-agent LLM framework to automate complex constraint-based metabolic modeling, effectively bridging the gap between natural language queries and genome-scale biological analysis. By converting therapeutic questions into executable workflows, this system demonstrates how AI can democratize access to specialized computational biology tools for hypothesis generation in disease contexts like rheumatoid arthritis and multiple sclerosis.
MechAInistic: An LLM-guided Multi-Agent System for Reasoning over Genome-Scale Constraint-Based Metabolic Models
arXiv:2607.18249v1 Announce Type: cross Abstract: Constraint-based metabolic modeling is a powerful way to study the mechanistic basis of cellular states and disease, but its effective use demands substantial computational expertise and careful coordination of multi-step analyses. We developed MechAInistic to lower this barrier and enable researchers to ask complex biological questions in natural language. Harnessing large language models, MechAInistic is a multi-agent system organized around an Architect-Reviewer pattern that transforms a natural-language question into an executable, model-grounded workflow and generates a structured report. The system supports a variety of tasks, including pathway comparison, perturbation analysis, drug-target exploration, and literature-grounded interpretation across paired metabolic model states. We developed and evaluated MechAInistic using two paired immune-cell metabolic-model use cases for therapeutic hypothesis generation. For Naive B cells from rheumatoid arthritis (RA) paired with healthy controls, MechAInistic identified mitochondrial metabolic rewiring and nominated Devimistat/CPI-613 as an investigational OGDH-centered hypothesis. In a paired CD4+ Th17 cell study from multiple sclerosis (MS) and healthy controls, the same workflow identified NADP-dependent isocitrate dehydrogenase as the optimal single target and proposed ivosidenib as an FDA-approved repurposing candidate. Together, these results show that MechAInistic converts natural-language biological questions into executable, model-grounded workflows for traceable therapeutic hypothesis generation.
Abstract:Constraint-based metabolic modeling is a powerful way to study the mechanistic basis of cellular states and disease, but its effective use demands substantial computational expertise and careful coordination of multi-step analyses. We developed MechAInistic to lower this barrier and enable researchers to ask complex biological questions in natural language. Harnessing large language models, MechAInistic is a multi-agent system organized around an Architect-Reviewer pattern that transforms a natural-language question into an executable, model-grounded workflow and generates a structured report. The system supports a variety of tasks, including pathway comparison, perturbation analysis, drug-target exploration, and literature-grounded interpretation across paired metabolic model states. We developed and evaluated MechAInistic using two paired immune-cell metabolic-model use cases for therapeutic hypothesis generation. For Naive B cells from rheumatoid arthritis (RA) paired with healthy controls, MechAInistic identified mitochondrial metabolic rewiring and nominated Devimistat/CPI-613 as an investigational OGDH-centered hypothesis. In a paired CD4+ Th17 cell study from multiple sclerosis (MS) and healthy controls, the same workflow identified NADP-dependent isocitrate dehydrogenase as the optimal single target and proposed ivosidenib as an FDA-approved repurposing candidate. Together, these results show that MechAInistic converts natural-language biological questions into executable, model-grounded workflows for traceable therapeutic hypothesis generation.
Quantitative Methods (q-bio.QM); Artificial Intelligence (cs.AI)
arXiv:2607.18249 [q-bio.QM]
(or arXiv:2607.18249v1 [q-bio.QM] for this version)
https://doi.org/10.48550/arXiv.2607.18249 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 289 words
Related coverage

A New Era of Discovery: Google Research at I/O 2026
Google Research · May 28, 2026
SciForge: An AI-Native, Multimodal Workbench for Scientific Discovery
arXiv · Jul 20, 2026

Transforming rare cancer research with Amazon Quick: Integrating biomedical databases for breakthrough discoveries
AWS · Jun 1, 2026

Presentation: Exploding GPUs
InfoQ · Oct 16, 2026